本届大会由中国干细胞与再生医学协同创新平台主办，北京干细胞与再生医学研究院、中国科学院 动物研究所承办，国家干细胞资源库等14家成员单位协办。 "会议成果既是我国生物技术标准化领域的重大突破，更是干细胞与类器官产业规范化与高质量发 展的重要里程碑。"中国科学院动物研究所研究员赵同标说，标准体系的建设将推动我国生物技术产业 深度参与国际合作，为全球科技创新生态建设做出积极贡献。 国际标准是全球通用的技术语言，也是促进技术国际合作与交流的核心要素。与会专家认为，标准 的出台将搭建科研与临床的转化桥梁，提高新药研发效率，为产业降低成本并减少风险。 记者从日前举行的第六届中国干细胞与再生医学协同创新平台大会上获悉，我国科研人员牵头组建 了国际标准化组织生物技术委员会类器官工作组。大会还为我国专家主导、多国参与的2项国际标准以 及中国细胞生物学学会制定的5项团体标准举行了发布仪式。 据了解，类器官是基于干细胞体外培养形成的、具有类似体内器官结构和功能的微型组织模型，能 精准模拟人体器官的生理状态与疾病进程，在生物医学领域价值重大。其可用于疾病精准诊断、个性化 药物筛选等，还能助力再生医学研究，为人类疾病治疗与健康保障开 ...

Core Insights - The establishment of the International Organization for Standardization (ISO) Biotechnology Committee's Organoid Working Group is a significant development in China's biotechnology standardization efforts [1] - Organoids, which are miniaturized tissue models derived from stem cells, have substantial value in biomedical fields, including precise disease diagnosis and personalized drug screening [1] - The conference outcomes mark a major breakthrough in the standardization of biotechnology in China and represent an important milestone for the standardized and high-quality development of the stem cell and organoid industry [1] Industry Developments - The conference was hosted by the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform, with support from various institutions including the Beijing Stem Cell and Regenerative Medicine Research Institute and the Chinese Academy of Sciences [2] - The release of two international standards and five group standards by the Chinese Society for Cell Biology highlights the collaborative efforts in establishing a standard system that will enhance China's participation in international cooperation [1] - The introduction of these standards is expected to bridge the gap between research and clinical applications, improve new drug development efficiency, and reduce costs and risks for the industry [1]